Top

Published in:

01-07-2012 | Original Article

Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells

Authors: Yihui Zhai, Jacek Bloch, Meike Hömme, Julia Schaefer, Thilo Hackert, Bärbel Philippin, Vedat Schwenger, Franz Schaefer, Claus P. Schmitt

Published in: Pediatric Nephrology | Issue 7/2012

Abstract

Background

Biocompatible peritoneal dialysis fluids (PDF) are buffered with lactate and/or bicarbonate. We hypothesized that the reduced toxicity of the biocompatible solutions might unmask specific effects of the buffer type on mesothelial cell functions.

Methods

Human peritoneal mesothelial cells (HPMC) were incubated with bicarbonate (B-)PDF or lactate-buffered (L-)PDF followed by messenger RNA (mRNA) and protein analysis. Gene silencing was achieved using small interfering RNA (siRNA), functional studies using Transwell culture systems, and monolayer wound-healing assays.

Results

Incubation with B-PDF increased HPMC migration in the Transwell and monolayer wound-healing assay to 245 ± 99 and 137 ± 11% compared with L-PDF. Gene silencing showed this effect to be entirely dependent on the expression of aquaporin-1 (AQP-1) and independent of AQP-3. Exposure of HPMC to B-PDF increased AQP-1 mRNA and protein abundance to 209 ± 80 and 197 ± 60% of medium control; the effect was pH dependent. L-PDF reduced AQP-1 mRNA. Addition of bicarbonate to L-PDF increased AQP-1 abundance by threefold; mRNA half-life remained unchanged. Immunocytochemistry confirmed opposite changes of AQP-1 cell-membrane abundance with B-PDF and L-PDF.

Conclusions

Peritoneal mesothelial AQP-1 abundance and migration capacity is regulated by pH and buffer agents used in PD solutions. In vivo studies are required to delineate the impact with respect to long-term peritoneal membrane integrity and function.

Yung S, Chan TM (2007) Mesothelial cells. Perit Dial Int 27(Suppl 2):S110–115PubMed

Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT (2002) Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13(2):470–479PubMed

Yang AH, Chen JY, Lin YP, Huang TP, Wu CW (1997) Peritoneal dialysis solution induces apoptosis of mesothelial cells. Kidney Int 51(4):1280–1288PubMedCrossRef

Jörres A, Bender TO, Finn A, Witowski J, Fröhlich S, Gahl GM, Frei U, Keck H, Passlick-Deetjen J (1998) Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int 54(6):2184–2193PubMedCrossRef

Witowski J, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Jörres A, Lage C, Schaub TP, Passlick-Deetjen J, Breborowicz A, Grzegorzewska A, Ksiazek A, Liberek T, Lichodziejewska-Niemierko M, Majdan M, Rutkowski B, Stompór T, Sulowicz W (2004) Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 19(4):917–924PubMedCrossRef

Hekking LH, Zareie M, Driesprong BA, Faict D, Welten AG, de Greeuw I, Schadee-Eestermans IL, Havenith CE, van den Born J, ter Wee PM, Beelen RH (2001) Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 12(12):2775–2786PubMed

Mortier S, Faict D, Lameire NH, De Vriese AS (2005) Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 67(4):1559–1565PubMedCrossRef

Wieczorowska-Tobis K, Brelinska R, Witowski J, Passlick-Deetjen J, Schaub TP, Schilling H, Breborowicz A (2004) Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit Dial Int 24(1):48–57PubMed

Choi HY, Kim DK, Lee TH, Moon SJ, Han SH, Lee JE, Kim BS, Park HC, Choi KH, Ha SK, Han DS, Lee HY (2008) The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int 28(2):174–182PubMed

10.

Lee HY, Choi HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL, Kim DJ, Kim YS, Kim MJ, Shin SK (2006) Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 21(10):2893–2899PubMedCrossRef

11.

Pannekeet MM, Mulder JB, Weening JJ, Struijk DG, Zweers MM, Krediet RT (1996) Demonstration of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients. Perit Dial Int 16(Suppl 1):S54–57PubMed

12.

Plum J, Razeghi P, Lordnejad RM, Perniok A, Fleisch M, Fusshöller A, Schneider M, Grabensee B (2001) Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells. Am J Kidney Dis 38(4):867–875PubMedCrossRef

13.

Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D (1988) The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34(3):404–411PubMedCrossRef

14.

Topley N, Kaur D, Petersen MM, Jörres A, Williams JD, Faict D, Holmes CJ (1996) In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function. J Am Soc Nephrol 7(2):218–224PubMed

15.

Lai KN, Li FK, Lan HY, Tang S, Tsang AW, Chan DT, Leung JC (2001) Expression of aquaporin-1 in human peritoneal mesothelial cells and its upregulation by glucose in vitro. J Am Soc Nephrol 12(5):1036–1045PubMed

16.

Ni J, Verbavatz JM (2006) Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 69(9):1518–1525PubMedCrossRef

17.

Yang B, Folkesson HG, Yang J, Matthay MA, Ma T, Verkman AS (1999) Reduced osmotic water permeability of the peritoneal barrier in aquaporin-1 knockout mice. Am J Physiol 276(1 Pt 1):C76–81PubMed

18.

Lai KN, Leung JC, Chan LY, Tang S, Li FK, Lui SL, Chan TM (2002) Expression of aquaporin-3 in human peritoneal mesothelial cells and its up-regulation by glucose in vitro. Kidney Int 62(4):1431–1439PubMedCrossRef

19.

Schoenicke G, Diamant R, Donner A, Roehrborn A, Grabensee B, Plum J (2004) Histochemical distribution and expression of aquaporin 1 in the peritoneum of patients undergoing peritoneal dialysis: relation to peritoneal transport. Am J Kidney Dis 44(1):146–154PubMedCrossRef

20.

Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD (1990) Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37(6):1563–70PubMedCrossRef

21.

Grossin N, Wautier MP, Wautier JL, Gane P, Taamma R, Boulanger E (2006) Improved in vitro biocompatibility of bicarbonate-buffered peritoneal dialysis fluid. Perit Dial Int 26(6):664–670PubMed

22.

Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, Pieper AK, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F (2003) Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephro 14(10):2632–2638CrossRef

23.

Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E (2003) Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 63(1):298–305PubMedCrossRef

24.

Albrektsson A, Bazargani F, Wieslander A, Braide M (2006) Peritoneal dialysis fluid-induced angiogenesis in rat mesentery is increased by lactate in the presence or absence of glucose. ASAIO J 52(3):276–281PubMedCrossRef

25.

Ogata S, Mori M, Tatsukawa Y, Kiribayashi K, Yorioka N (2006) Expression of vascular endothelial growth factor, fibroblast growth factor, and lactate dehydrogenase by human peritoneal mesothelial cells in solutions with lactate or bicarbonate or both. Adv Perit Dial 22:37–40PubMed

26.

Papadopoulos MC, Saadoun S, Verkman AS (2008) Aquaporins and cell migration. Pflugers Arch 456(4):693–700PubMedCrossRef

27.

Hayashi S, Takahashi N, Kurata N, Yamaguchi A, Matsui H, Kato S, Takeuchi K (2009) Involvement of aquaporin-1 in gastric epithelial cell migration during wound repair. Biochem Biophys Res Commun 386(3):483–487PubMedCrossRef

28.

Hu J, Verkman AS (2006) Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J 20(11):1892–1894PubMedCrossRef

29.

Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS (2005) Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 434(7034):786–792PubMedCrossRef

30.

Hara-Chikuma M, Verkman AS (2008) Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med 86(2):221–231PubMedCrossRef

31.

Garner MM, Burg MB (1994) Macromolecular crowding and confinement in cells exposed to hypertonicity. Am J Physiol 266(4 Pt 1):C877–92PubMed

32.

Boron WF (2006) Acid-base transport by the renal proximal tubule. J Am Soc Nephrol 17(9):2368–2382PubMedCrossRef

33.

Endeward V, Musa-Aziz R, Cooper GJ, Chen LM, Pelletier MF, Virkki LV, Supuran CT, King LS, Boron WF, Gros G (2006) Evidence that aquaporin 1 is a major pathway for CO2 transport across the human erythrocyte membrane. FASEB J 20(12):1974–1981PubMedCrossRef

34.

Musa-Aziz R, Chen LM, Pelletier MF, Boron WF (2009) Relative CO2/NH3 selectivities of AQP-1, AQP4, AQP5, AmtB, and RhAG. Proc Natl Acad Sci USA 106(13):5406–5411PubMedCrossRef

35.

Nakhoul NL, Davis BA, Romero MF, Boron WF (1998) Effect of expressing the water channel aquaporin-1 on the CO2 permeability of Xenopus oocytes. Am J Physiol 274(2 Pt 1):C543–548PubMed

36.

Prasad GV, Coury LA, Finn F, Zeidel ML (1998) Reconstituted aquaporin 1 water channels transport CO2 across membranes. J Biol Chem 273(50):33123–33126PubMedCrossRef

37.

Missner A, Kügler P, Saparov SM, Sommer K, Mathai JC, Zeidel ML, Pohl P (2008) Carbon dioxide transport through membranes. J Biol Chem 12;283(37):25340–7CrossRef

38.

Waisbren SJ, Geibel JP, Modlin IM, Boron WF (1994) Unusual permeability properties of gastric gland cells. Nature 24;368(6469):332–5CrossRef

39.

Plum J, Lordnejad MR, Grabensee B (1998) Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes. Kidney Int 54(2):677

40.

Ogata S, Naito T, Yorioka N, Kiribayashi K, Kuratsune M, Kohno N (2004) Effect of lactate and bicarbonate on human peritoneal mesothelial cells, fibroblasts and vascular endothelial cells, and the role of basic fibroblast growth factor. Nephrol Dial Transplant 19(11):2831–7PubMedCrossRef

41.

Plum J, Hermann S, Fusshöller A, Schoenicke G, Donner A, Röhrborn A, Grabensee B (2001) Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int Suppl 78:S42–7PubMedCrossRef

42.

Zhou FQ (2005) Pyruvate in the correction of intracellular acidosis: a metabolic basis as a novel superior buffer. Am J Nephrol 25(1):55–63PubMedCrossRef

43.

Schmitt CP, von Heyl D, Rieger S, Arbeiter K, Bonzel KE, Fischbach M, Misselwitz J, Pieper AK, Schaefer F, for the Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS) (2007) Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content. Nephrol Dial Transplant 22(7):2038–44PubMedCrossRef

44.

Frischmann M, Spitzer J, Fünfrocken M, Mittelmaier S, Deckert M, Fichert T, Pischetsrieder M (2009) Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids. Biomed Chromatogr 23:843–851PubMedCrossRef

45.

Erixon M, Wieslander A, Lindén T, Carlsson O, Forsbäck G, Svensson E, Jönsson JA, Kjellstrand P (2006) How to avoid glucose degradation products in peritoneal dialysis fluids. Perit Dial Int 26:490–497PubMed

Title: Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells
Authors: Yihui Zhai
Jacek Bloch
Meike Hömme
Julia Schaefer
Thilo Hackert
Bärbel Philippin
Vedat Schwenger
Franz Schaefer
Claus P. Schmitt
Publication date: 01-07-2012
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 7/2012
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-012-2120-1

At a glance: The STEP trials

Springer Medicine

Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2012

Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant

Understanding renal posttransplantation anemia in the pediatric population

Alport-like glomerular basement membrane changes with renal-coloboma syndrome

The PDGF family in renal fibrosis

Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease

Urological anomalies and chronic kidney disease in children with anorectal malformations